Public Inspection: FDA: Guidance: Opioid Use Disorder: Endpoints for Demonstrating Effectiveness of Drugs for Medication-Assisted Treatment

Pre-publication notice from the Food and Drug Administration seeking comment on a draft guidance entitled "Opioid Use Disorder: Endpoints for Demonstrating Effectiveness of Drugs for Medication-Assisted Treatment," as well as comments on when the use of placebo or active controls is most appropriate in clinical trials for such drugs. Comments are due within 60 days of official publication of this notice in the Federal Register, which is scheduled for August 7, 2018.
Source: Federal Register updates via the Rural Assistance Center - Category: Rural Health Source Type: news